ライフサイエンスコーパス: capsular

1 h asymptomatic and symptomatic patients, and capsular adhesions at the anterior femoral neck were pre

2 Results Capsular adhesions at the anterior femoral neck were pre

3 ence of abnormal imaging findings, including capsular adhesions at the femoral neck, obliteration of

4 oughput screen for gene products involved in capsular alpha-glucan production.

5 NA in the environment may traverse the thick capsular and cell wall layers remains unknown.

6 infants were obtained in parallel and their capsular and pilus types were identified by serological

7 We compared GBS capsular and surface-protein maternal immunoglobin G ant

8 stabilize anterior chamber volume, maintain capsular and zonular integrity, and protect the corneal

9 lacentally transferred GBS serotype-specific capsular antibodies in the infants and their immune resp

10 The adjusted odds of having capsular antibody concentration >/=2 microg/mL when comp

11 Median capsular antibody concentrations (microg/mL) were lower

12 roup B streptococcus (GBS) serotype-specific capsular antibody concentrations are correlated with sus

13 vaccine that produces both the protective F1 capsular antigen of Yersinia pestis and the LcrV protein

14 ytosis that is independent of polysaccharide capsular antigen.

15 lasticity, antibiotic resistance and extreme capsular antigenic variation complicates the design of e

16 Microbial capsular antigens are effective vaccines but are chemica

17 ognition motif can be used to assembly a 2:1 capsular architecture with a linear diammonium axle.

18 or, in which three K(+) encapsulated dimeric capsular assemblies interdigitate to form a precise cavi

19 K(+) and HPO4(2-) via formation of a dimeric capsular assembly of the receptor, in which three K(+) e

20 To enhance capsular association strength, tuning the XB donor is mo

21 , the modified heptose branches off from the capsular backbone and is directly exposed to the environ

22 ith PLYh-expressing strains, irrespective of capsular background.

23 to ST8 PLYa in a homologous and heterologous capsular background.

24 ment of a case of intraocular lens (IOL) and capsular bag (CB) dislocation in an eye with an Ahmed gl

25 werful IOL (Acrysof SA60AT) implanted in the capsular bag (range of powers +35.0 to +40.0 diopters [D

26 is, pearl, mixed type and late-postoperative capsular bag distension syndrome.

27 lowed by mixed, pearl and late-postoperative capsular bag distension syndrome.

28 placed in the sulcus for 14 eyes and in the capsular bag for 3 eyes, and glued intrascleral fixation

29 managed with PPV and removal of the IOL and capsular bag had better visual outcomes.

30 ntation, with successful preservation of the capsular bag in 90% of eligible cases, especially in eye

31 raocular lens was successfully placed in the capsular bag in all cases.

32 educed cell coverage in both closed and open capsular bag models.

33 nts (56%) who had intraocular lens (IOL) and capsular bag removals had better final BCVAs than those

34 te the feasibility of drug delivery from the capsular bag to the anterior and posterior segments effe

35 The capsular bag was preserved in 43 eyes (91.5%).

36 nted into residual lens tissue, known as the capsular bag, following cataract removal.

37 Three different IOLs were implanted in the capsular bag.

38 ain outcome measure was the retention of the capsular bag.

39 Explanted capsular bags from 3 of these patients were compared wit

40 Histologic examination of the explanted capsular bags revealed a paucicellular membrane that cov

41 such a case of moderate ipsilateral ganglio-capsular bleed of unknown cause with associate aortic ar

42 C8 targets capsular carbohydrate on the bacterial surface, enhancin

43 ersatility in surface functionalization) and capsular configurations (e.g., a large inner cavity, low

44 lens dislocation may result from progressive capsular contraction secondary to retinal detachment-ind

45 ion to vascularization of the lens through a capsular dehiscence, other causes are explored, includin

46 lid-type synovitis, synovial thickening, and capsular dehiscence.

47 In this respect, a previously proposed capsular device able to control the release performance

48 ations were made regarding uniformity of the capsular edge and the presence of irregularities that ma

49 y sampling showed a generally uniform rolled capsular edge, but interspersed with areas of irregulari

50 at TTPA also exhibits lytic activity towards capsular exopolysaccharide (EPS) of the multiresistant c

51 red interaction between epithelial cells and capsular extracellular matrix in DKO lenses.

52 in corneal edema, AC inflammatory reaction, capsular fibrosis, ACO, and PCO.

53 corrected visual acuity, rhexis-IOL overlap, capsular folds, or anterior capsule opacification.

54 mercury and was preferentially found in the capsular fraction.

55 ght the difficulties in the serogrouping and capsular genogrouping of meningococcal carriage isolates

56 Capsular genogroups detected by broth culture were genog

57 chedules of vaccination with glyco-conjugate capsular group C Neisseria meningitidis (Men C) vaccines

58 eceived the combined H influenzae type b and capsular group C Neisseria meningitidis tetanus toxoid c

59 suring variant-specific PorA IgG antibodies, capsular group Y IgG antibodies and serum bactericidal a

60 18.2% [95% CI 3.4-30.8] carriage reduction), capsular groups BCWY (26.6% [10.5-39.9] carriage reducti

61 BCWY (26.6% [10.5-39.9] carriage reduction), capsular groups CWY (29.6% [8.1-46.0] carriage reduction

62 Together, our findings suggest that the capsular heptose modification pathway contributes to bac

63 Maternal anti-capsular IgG concentrations above 1 microg/mL mediated G

64 Moreover, maternal anti-capsular IgG concentrations showed a significant correla

65 , the SEM features raise safety concerns for capsular integrity after FLACS and warrant further inves

66 (HR, 2.38; 95% CI, 1.27-4.48; P = .01), and capsular invasion (HR, 1.96; 95% CI, 1.02-3.74; P = .04)

67 he greatest increase in CDFS3 over time (eg, capsular invasion: 28%-88%, Delta60% vs no capsular inva

68 , capsular invasion: 28%-88%, Delta60% vs no capsular invasion: 51%-87%, Delta36%).

69 f cell wall assembly, was made in a directed capsular knockout of strain D39, thereby avoiding potent

70 on histologic findings consisting of diffuse capsular lamellar separation and anterior zonular disrup

71 Capsular lamellar separation and anterior zonular disrup

72 Arrangement of the capsular-like polysaccharides into a rigid spore coat re

73 ancreas with organized collection in the sub-capsular location indenting the superior pole of the lef

74 than 1960, and the imported DNA included the capsular locus and the nearby penicillin-binding protein

75 f these antigen preparations, termed protein capsular matrix vaccines (PCMVs), will likely provide im

76 t is due to profound mAb-mediated changes in capsular mechanical properties, demonstrated by a concen

77 s a high incidence of postsurgical posterior capsular opacification (18/19, 95%).

78 mation, corneal endothelial damage, anterior capsular opacification (ACO), and posterior capsular opa

79 application for the management of posterior capsular opacification (PCO).

80 capsular opacification (ACO), and posterior capsular opacification (PCO).

81 lar tension ring use, incidence of posterior capsular opacification and neodymium-doped yttrium-alumi

82 cuity, incidence of macular edema, posterior capsular opacification, epiretinal membrane, and intraoc

83 With time, capsular opacities (posterior only or posterior and ante

84 investigated the relationship of ex vivo CSF capsular phenotype with ICP and CSF immune response, as

85 Solid-phase fixation of the engineered capsular polymerases enabled rapid production of capsula

86 st step, the elongation modes of recombinant capsular polymerases from Neisseria meningitidis serogro

87 e solution behaviour of native and activated capsular polyribosylribitol (PRP) polysaccharides extrac

88 ategy was selected to elicit opsonizing anti-capsular polysaccharide (anti-CPS) IgG antibodies.

89 The capsular polysaccharide (capsule) is a critical virulenc

90 Genes encoding S. aureus capsular polysaccharide (CP) biosynthesis, PglB (a Campy

91 In Staphylococcus aureus, the capsular polysaccharide (CP) protects against phagocytos

92 Here, we report that the type 5 capsular polysaccharide (CP5) of Staphylococcus aureus N

93 crucial to first systematically characterize capsular polysaccharide (CPS) and virulence traits in th

94 e A O-polysaccharide (OPS) and manno-heptose capsular polysaccharide (CPS) antigens were isolated fro

95 hogenesis, expression of a surface-localized capsular polysaccharide (CPS) can be critical for surviv

96 In the present study, the 6-deoxyheptan capsular polysaccharide (CPS) from B. pseudomallei was p

97 The transcription of the capsular polysaccharide (cps) locus is not well understo

98 l in blood, of which 75% were members of the capsular polysaccharide (cps) operon.

99 tigated the effect of oxygen availability on capsular polysaccharide (CPS) production and biofilm for

100 hetic glycans resembling portions of the ST2 capsular polysaccharide (CPS) repeating unit were used t

101 Glycoconjugate vaccines based on isolated capsular polysaccharide (CPS) save millions of lives ann

102 coccus pneumoniae (pneumococcus) expresses a capsular polysaccharide (CPS) that protects against host

103 city-matched mothers colonized with the same capsular polysaccharide (CPS) types delivering healthy n

104 They express the same capsular polysaccharide (CPS), a homopolymer featuring a

105 C. jejuni is known to produce capsular polysaccharide (CPS), but the specific role tha

106 A major virulence factor of Nm is the capsular polysaccharide (CPS), which in Nm serogroup A c

107 nes leading to structural variability of the capsular polysaccharide (CPS).

108 ns (O-polysaccharide [OPS] and 6-deoxyheptan capsular polysaccharide [CPS]) and two crude antigens (w

109 Purified serotype 5 capsular polysaccharide also exhibited antibiofilm activ

110 tical IgE and IgA to Cryptococcus neoformans capsular polysaccharide and found that these differed in

111 Insights into the interactions between the capsular polysaccharide and its transporter and the mech

112 f the hexasaccharide repeating unit from its capsular polysaccharide and related sequences.

113 tigated the role of Abs to the mycobacterial capsular polysaccharide arabinomannan (AM) and its oligo

114 sulated pathogen, and antibodies against the capsular polysaccharide are protective.

115 uces capsular polysaccharide identical to 6B capsular polysaccharide as determined by one-dimensional

116 First, the entire 24-kb capsular polysaccharide biosynthesis locus, which is ess

117 One spot comprising a mixture of capsular polysaccharide biosynthesis protein and other p

118 A-85/14 to confirm the presence of a unique capsular polysaccharide biosynthetic locus.

119 Presence of serotype-specific capsular polysaccharide cell-mediated immunity contribut

120 roup B Streptococcus (GBS) serotype-specific capsular polysaccharide cellular immunity, measured with

121 vocal evidence to our knowledge that nascent capsular polysaccharide chains exit the cell through the

122 ction, mice were immunized with pneumococcal capsular polysaccharide conjugate vaccine, and then sequ

123 Capsular polysaccharide conjugate vaccines have been tes

124 tions (Ia, Ib, II-IX), and current candidate capsular polysaccharide conjugate vaccines target only a

125 The capsular polysaccharide consists of polyhexosamine phosp

126 in deficient in the production of serotype 5 capsular polysaccharide did not exhibit antibiofilm acti

127 he structural basis of immune recognition of capsular polysaccharide epitopes can aid in the design o

128 in the design of novel therapeutics to block capsular polysaccharide export.

129 Protein glycosylation and capsular polysaccharide formation are increasingly recog

130 olecular primary and secondary structures of capsular polysaccharide from C. psychrerythraea 34H cell

131 catalytic 18B7 antibody increases release of capsular polysaccharide from fungal cells.

132 re in the outer membrane that transports K30 capsular polysaccharide from its site of synthesis to th

133 multibranched hexasaccharide related to the capsular polysaccharide from Streptococcus pneumoniae ty

134 e element (ACME), and a specific mutation in capsular polysaccharide gene cap5E Although the PVL-enco

135 used to study the contributions of bacterial capsular polysaccharide I (CPS I) to virulence during ac

136 res of the putative serotype 6E but produces capsular polysaccharide identical to 6B capsular polysac

137 Its capsular polysaccharide is essential for systemic virule

138 The Campylobacter jejuni capsular polysaccharide is important for virulence and o

139 in the Campylobacter jejuni NCTC11168 (HS:2) capsular polysaccharide is reported.

140 It produces a capsular polysaccharide known as "Vi antigen," which is

141 mutant (AB307.30) was shown, suggesting that capsular polysaccharide mediated the inhibition of MAb b

142 rease involved mAb-mediated cross-linking of capsular polysaccharide molecules.

143 ainst the 23F serotype of the pneumonococcal capsular polysaccharide of Streptococcus pneumoniae and

144 an antigenic carrier protein coupled to the capsular polysaccharide of the bacterial pathogen, are t

145 cifically bind to the lipopolysaccharide and capsular polysaccharide of V. cholerae O139.

146 anic phosphate (Pi) metabolism in modulating capsular polysaccharide production.

147 Adhesion and translocation were dependent on capsular polysaccharide production.

148 ynthesis of the Staphylococcus aureus type 5 capsular polysaccharide repeating unit, a trisaccharide

149 Although its capsular polysaccharide structure has not been elucidate

150 d very small amounts of fragments of the K30 capsular polysaccharide substrate reveal the translocati

151 The capsular polysaccharide surrounding N. meningitidis is a

152 mmunity and is synthesized by enzymes in the capsular polysaccharide synthesis (cps) locus.

153 ions, such as polysaccharide utilization and capsular polysaccharide synthesis loci.

154 GBS bacteria are surrounded by a thick capsular polysaccharide that is a potent inhibitor of co

155 in vitro experiments, using an inhibitor of capsular polysaccharide transport, enabled potent bacter

156 synthesis of the repeating unit of S. aureus capsular polysaccharide type 5 equipped with capping met

157 The Group B Streptococcus capsular polysaccharide type IX was isolated and purifie

158 le for the differentiation between the three capsular polysaccharide types, leading us to hypothesize

159 Capsular polysaccharide vaccines are available against m

160 Capsular polysaccharide was also protective against comp

161 reptococcus pneumoniae produces a protective capsular polysaccharide whose production must be modulat

162 In conclusion, we show that capsular polysaccharide, a critical meningococcal virule

163 produce either a serotype 5 (CP5) or 8 (CP8) capsular polysaccharide, and the CP antigens are targets

164 Neisseria meningitidis utilizes capsular polysaccharide, lipooligosaccharide (LOS) siali

165 ular glucuronoxylomannan (GXM), the major Cn capsular polysaccharide, LPS-induced nuclear translocati

166 ecules-peptidoglycan, lipopolysaccharide and capsular polysaccharide-either simultaneously or individ

167 Capsular polysaccharide-specific immunoglobin (Ig) G and

168 sive Neisseria meningitidis isolates express capsular polysaccharide.

169 ons in the antibody response to pneumococcal capsular polysaccharides (caps-PSs) is controversial.

170 ired immunoglobulin G (IgG) responses to GBS capsular polysaccharides (CPS) and pilus proteins in Eur

171 Bacterial capsular polysaccharides (CPS) are complex carbohydrate

172 acid (WTA) in bacilli and staphylococci and capsular polysaccharides (CPS) in streptococci.

173 characterization of Streptococcus pneumoniae capsular polysaccharides (CPS) is a prerequisite for unr

174 The production of capsular polysaccharides (CPS) or secreted exopolysaccha

175 des, including lipopolysaccharides (LPS) and capsular polysaccharides (CPS), are implicated in the ad

176 Capsular polysaccharides (CPSs) are high-molecular-mass

177 Capsular polysaccharides (CPSs) play multiple roles in p

178 Streptococcus pneumoniae expresses capsular polysaccharides (CPSs) to protect itself from o

179 acteria express surface carbohydrates called capsular polysaccharides (CPSs).

180 Over 90 serologically distinct pneumococcal capsular polysaccharides (serotypes) are recognized, but

181 Zwitterionic capsular polysaccharides (ZPSs) are bacterial products t

182 id (beta-Kdo) glycosides are mainly found in capsular polysaccharides and extracellular exopolysaccha

183 Although recent studies have shown that shed capsular polysaccharides and intact extracellular Cn can

184 These results demonstrate that capsular polysaccharides and intact intracellular yeast

185 for a systemic pathogen, with production of capsular polysaccharides and maintenance of the peptidog

186 coccal native, micro-fluidized and activated capsular polysaccharides and their glycoconjugates - in

187 th repetitive structures including bacterial capsular polysaccharides and viral capsids elicit antibo

188 atic steps involved in the production of the capsular polysaccharides are emerging, information regar

189 Capsular polysaccharides are known virulence factors of

190 Capsular polysaccharides are the primary antigenic compo

191 tly, it has been shown that a large group of capsular polysaccharides from Gram-negative bacteria, pr

192 xy-beta-d-ido-heptopyranoside related to the capsular polysaccharides of C. jejuni HS:4 is very remar

193 t surface of this cell envelope is formed by capsular polysaccharides that play an important role in

194 charide of beta-Kdo residues links "group 2" capsular polysaccharides to (lyso)phosphatidylglycerol.

195 present processed fragments of zwitterionic capsular polysaccharides to T cells.

196 ular polymerases enabled rapid production of capsular polysaccharides with high yield and purity.

197 s and also to bacterial lipopolysaccharides, capsular polysaccharides, and lipoarabinomannans that co

198 ctively exhibited a strong overproduction of capsular polysaccharides, including alpha-glucan and ara

199 d for production of the constitutive group 1 capsular polysaccharides, which act as virulence determi

200 d class-switched IgG antibodies to microbial capsular polysaccharides, which decreased in PTX3-defici

201 thought to attach teichoic acid polymers and capsular polysaccharides.

202 tivating pathogens and purification of their capsular polysaccharides.

203 m-negative bacteria is composed of bacterial capsular polysaccharides.

204 We found no difference in mean (SEM) capsular porosity between the CERA (3.39 [0.76; 95% CI,

205 imental method permits direct measurement of capsular porosity of an in situ GDD.

206 Mean (SEM) capsular porosity of CERA GDDs connected to the anterior

207 sting GDD, no differences were identified in capsular porosity or histologic reaction between the imp

208 We measured the capsular porosity using a pressure-gated picoliter pump

209 function of Gpx4 both as an enzyme oxidizing capsular protein thiols and as a structural protein, tig

210 proper oxidation and polymerization of sperm capsular proteins and malformation of the mitochondrial

211 covalently associated with cell wells (e.g., capsular PS (CPS)).

212 anterior-posterior, dorsal-ventral, and core-capsular relationships.

213 ning electron microscopy and ultrastructural capsular remnants by transmission electron microscopy.

214 Here we show that capsular RSPO3 signals to the underlying steroidogenic c

215 ntly more likely than tip occlusion to cause capsular rupture (63.3% vs 0%, P < .0001).

216 CI, 5.84-6.41), vitrectomy for perioperative capsular rupture (HR, 4.36; 95% CI, 4.07-4.68), history

217 Posterior capsular rupture (PCR) and vitreous loss are inevitable

218 To investigate the risk of posterior capsular rupture (PCR) during cataract surgery in eyes w

219 SICS), as well as in patients with posterior capsular rupture (PCR).

220 cosal ulceration in 4 patients, preoperative capsular rupture in 1, and no incomplete resections.

221 For patients with a perioperative capsular rupture of the lens (the major risk factor for

222 There were no instances of posterior capsular rupture or significant surgical complications i

223 ities, systemic comorbidities, and posterior capsular rupture status.

224 sound was significantly more likely to cause capsular rupture than micropulsed ultrasound (69.8% vs 5

225 here is no significant difference in risk of capsular rupture using Venturi rather than peristaltic v

226 Posterior capsular rupture was associated with a 3.68-fold increas

227 and its use for patients with perioperative capsular rupture where the risk of POE is dramatically i

228 Tip occlusion is not a risk factor for capsular rupture, as all breaks in the capsular surrogat

229 actors for RD onset: high myopia, young age, capsular rupture, history of eye trauma, extracapsular e

230 d peristaltic pump modes had similar risk of capsular rupture, regardless of whether the data were an

231 ive intraoperative management strategies for capsular rupture.

232 for patients with or without a perioperative capsular rupture.

233 without any mucosal ulceration, preoperative capsular ruptures, or incomplete resections.

234 omplex with CO3(2-) via formation of dimeric capsular self-assembly of the receptor.

235 three major genetic clusters of serotype 6A capsular sequences, discovered a new hybrid 6C/6E seroty

236 lls of Gram-negative Neisseria meningitidis, capsular serogroup C (MenC) or Gram-positive group B Str

237 The global drug-susceptible capsular serotype 12F, clonal complex 218 caused several

238 ile others (such as the associations between capsular serotype and lineage) remain in continuous flux

239 Associations exist between lineage and capsular serotype but these can be easily perturbed, suc

240 Group B streptococcus (GBS) capsular serotypes are major determinants of virulence a

241 rvirulent strains belonging to the K1 and K2 capsular serotypes, predominantly in eastern Asia.

242 nt resistance and invasive potential between capsular serotypes.

243 ly diverse, exhibiting a variety of distinct capsular serotypes.

244 sent and where the perimeter of CD169(+) sub capsular sinus macrophages was disrupted.

245 Ex vivo capsular size and shedding did not correlate with that o

246 Induced capsular size and shedding were measured in vitro for 48

247 The vaccine was well tolerated and induced capsular-specific antibody responses, in non-pregnant an

248 Initial capsular splits occur along the insertions of disrupted

249 These data suggest that lymph node capsular status is an important prognostic factor and sh

250 found to template an otherwise inaccessible capsular structure in a manner usually associated with s

251 Seven eyes of 4 children without adequate capsular support had posterior chamber iris-claw aphakic

252 patients (222 males and 98 females) without capsular support in which we performed RPICIOL implantat

253 intraocular lens in cases of aphakia without capsular support is debated.

254 ICIOL) in several aphakic conditions without capsular support.

255 tants were constructed, and the loss of O-Ag capsular surface expression was confirmed through micros

256 r for capsular rupture, as all breaks in the capsular surrogate occurred with tip contact.

257 Contact was made with a capsular surrogate to achieve tip occlusion or tip conta

258 akage rates were calculated by analyzing the capsular surrogate under a surgical microscope.

259 evidence could be found for vaccine induced capsular switches.

260 Genotyping suggests that capsular switching has occurred between MDR vaccine sero

261 ll proportion of isolates showed evidence of capsular switching in both periods.

262 e considered for inclusion, with evidence of capsular switching in CC17 strains.

263 d for monitoring for serotype replacement or capsular switching.

264 Toronto, which revealed multiple episodes of capsular switching.

265 ive ocular AEs included 119 (0.55%) cases of capsular tear and 73 (0.34%) cases of vitreous loss.

266 The rate of posterior capsular tear was 0.20%, with a higher proportion from e

267 oma cases were more likely to have posterior capsular tear with vitrectomy (odds ratio [OR] 1.8, P =

268 uma, intraoperative iris prolapse, posterior capsular tear, anterior capsule tear, intraoperative vit

269 0.74 to 6.23; P = 0.16); however, posterior capsular tears were significantly more common in FLACS v

270 concentrations and higher rates of posterior capsular tears.

271 To discuss capsular tension devices and recent evidence regarding t

272 r-assisted cataract surgery, with the use of capsular tension devices.

273 n segment in conjunction with a conventional capsular tension ring appears to be a safe and effective

274 n segment in conjunction with a conventional capsular tension ring between January 1, 2009 and March

275 in-the-bag IOL with either a Cionni modified capsular tension ring or a capsular tension segment in c

276 in-the-bag IOL with either a Cionni modified capsular tension ring or a capsular tension segment in c

277 sual acuity (BCVA), lens and zonular status, capsular tension ring use, incidence of posterior capsul

278 a capsular tension segment with an unsutured capsular tension ring was implanted in 12 eyes.

279 A Cionni modified capsular tension ring was implanted in 5 eyes and a caps

280 The capsular tension ring, modified capsular tension ring, and capsular tension segment are

281 The capsular tension ring, modified capsular tension ring, a

282 In 2 eyes, capsular tension segment alone was placed.

283 on ring, modified capsular tension ring, and capsular tension segment are well established tools for

284 a Cionni modified capsular tension ring or a capsular tension segment in conjunction with a conventio

285 a Cionni modified capsular tension ring or a capsular tension segment in conjunction with a conventio

286 r tension ring was implanted in 5 eyes and a capsular tension segment with an unsutured capsular tens

287 e capacities, many studies have investigated capsular thickness or the interaction of the capsule wit

288 han the equatorial zonule and that choice of capsular thickness values can influence the results from

289 carrying pneumococcal serotypes with greater capsular thickness, neutrophil resistance, and metabolic

290 ide range of angles of force application and capsular thickness.

291 vironment (aqueous and vitreous humors), the capsular tissue, and the intraocular lens (IOL) surfaces

292 strain (19F ST320), we analyzed the role of capsular type and genetic background on the difference i

293 enC) or Gram-positive group B Streptococcus, capsular type III (GBS-III) bacteria resulted in augment

294 capsule depolymerase exhibit specificity for capsular type K1 and can be used for the diagnosis and t

295 K1-1) that infects K. pneumoniae NTUH-K2044 (capsular type K1) was isolated and characterized.

296 ntly, most frequently associated with the K1 capsular type.

297 le, the genes for biosynthesis of almost all capsular types are arranged in the same locus.

298 creased serotype assignment (100%) to all 10 capsular types.

299 strains, and none of the strains with other capsular types.

300 used to perform multilocus sequence typing, capsular typing, and identification of virulence and ant

301 Capsular Vi-polysaccharide-protein conjugate vaccines (V